A leadership on Sickle Cell Disease
INNOVHEM designs, develops and manufactures scientific and medical innovations to improve the standard-of-care of sickle cell patients to improve their quality of life.
INNOVHEM is built on more than a decade of expertise in the clinical management of sickle cell disease and other hematological malignancies such as thalassemia. This expertise is rooted in the extensive experience of our co-founder and CSO, Prof. Pablo Bartolucci.
INNOVHEM is composed of a team of expert scientists, dedicated to high quality science as a means to advancing developments in the sickle cell landscape. Our goal is to provide high-value medical products and services that exceed customer and patient expectations.